Joel Greenblatt’s Mead Johnson Nutrition Company MJN Stock Holding History

Joel Greenblatt’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-67,513	Closed	-$4.78M	–	1174
2016 Q4	$4.78M	Sell	67,513 -9,654	-13%	-$719K	0.06%	388
2016 Q3	$6.1M	Buy	+77,167	New	+$6.58M	0.08%	326
2015 Q4	–	Sell	-687,078	Closed	-$48.4M	–	1069
2015 Q3	$48.4M	Buy	687,078 +488,149	+245%	+$40.2M	0.47%	54
2015 Q2	$17.9M	Buy	198,929 +190,264	+2,196%	+$18.3M	0.15%	219
2015 Q1	$871K	Buy	+8,665	New	+$874K	0.01%	618
2014 Q3	–	Sell	-5,758	Closed	-$536K	–	1118
2014 Q2	$536K	Buy	+5,758	New	+$503K	0.01%	771
2014 Q1	–	Sell	-9,546	Closed	-$800K	–	1137
2013 Q4	$800K	Buy	+9,546	New	+$777K	0.02%	670

Other funds holding MJN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Joel Greenblatt's MJN Position: Q1 2017 in Review

Joel Greenblatt sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 67,513 shares — an estimated $4.78M sold.

Joel Greenblatt first reported a position in MJN in Q4 2013 and held it in 7 quarters. The position peaked at $48.4M in Q3 2015. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

Joel Greenblatt reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
Joel Greenblatt sold 67,513 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $4.78M.
Joel Greenblatt first reported a position in Mead Johnson Nutrition Company in Q4 2013 and held it in 7 quarters.
Joel Greenblatt's Mead Johnson Nutrition Company position peaked at $48.4M in Q3 2015.
533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Gotham Asset Management's 13F filing for Q1 2017, filed 15 May 2017.